|
MechanismPeptidoglycan inhibitors [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date11 Sep 2009 |
100 Clinical Results associated with Theravance Biopharma Ireland Umited
0 Patents (Medical) associated with Theravance Biopharma Ireland Umited
100 Deals associated with Theravance Biopharma Ireland Umited
100 Translational Medicine associated with Theravance Biopharma Ireland Umited